CVE-2008-5266

Description

Cross-site scripting (XSS) vulnerability in configuration/httpListenerEdit.jsf in the GlassFish 2 UR2 b04 webadmin interface in Sun Java System Application Server 9.1_01 build b09d-fcs and 9.1_02 build b04-fcs allows remote attackers to inject arbitrary web script or HTML via the name parameter, a different vector than CVE-2008-2751.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 1.05% Top 25%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://securityreason.com/securityalert/4659 third party advisory
http://www.securityfocus.com/archive/1/493243/100/0/threaded mailing list
http://webappsecurity.wordpress.com/2008/06/11/xss-glassfish-web-admin-interface-sun-java-system-application/
https://exchange.xforce.ibmcloud.com/vulnerabilities/47029 vdb entry
http://secunia.com/advisories/30604 third party advisory vendor advisory
http://www.securityfocus.com/bid/29646 vdb entry

Frequently Asked Questions

What is the severity of CVE-2008-5266?
CVE-2008-5266 has been scored as a medium severity vulnerability.
How to fix CVE-2008-5266?
To fix CVE-2008-5266, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-5266 being actively exploited in the wild?
It is possible that CVE-2008-5266 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.